Sanofi (SNY) Shares Outstanding (Weighted Average) (2009 - 2026)

Sanofi has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $1.4 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.4 million, up 8.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 8.62% YoY), and the FY2025 annual result was $2.8 billion, up 112.31% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.4 million for Q1 2026 at Sanofi, down from $2.8 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.8 billion in Q4 2025 to a low of $847362.2 in Q1 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $634.7 million (2025), against an average of $761.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 99.94% in 2024 and surged 125.85% in 2025, its largest moves.
• Sanofi's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then rose by 5.44% to $1.3 billion in 2023, then fell by 0.71% to $1.3 billion in 2024, then soared by 112.31% to $2.8 billion in 2025, then slumped by 99.95% to $1.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.4 million (Q1 2026), $2.8 billion (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.